Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-23
1999-09-14
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142388, 514428, 514650, 540609, 544106, 546195, 546205, 548528, 548576, 564337, 564347, 564353, 564354, A61K 31445, C07D21106
Patent
active
059523506
ABSTRACT:
The invention provides a compound of formula I: ##STR1## or a pharmaceutically acceptable salt or solvate thereof; pharmaceutical compositions containing a compound of formula I, and methods of using a compound of formula I for inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia, and estrogen dependent cancer.
REFERENCES:
patent: 3274213 (1966-09-01), Lednicer et al.
patent: 3394125 (1968-07-01), Crenshaw
patent: 3413305 (1968-11-01), Crenshaw
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4358593 (1982-11-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones et al.
patent: 5147880 (1992-09-01), Jones et al.
patent: 5395842 (1995-03-01), Labrie
patent: 5470854 (1995-11-01), Angerer et al.
patent: 5472962 (1995-12-01), Koizumi et al.
patent: 5484795 (1996-01-01), Bryant et al.
patent: 5552412 (1996-09-01), Cameron et al.
Bindal et al. "1,2-diaryl-3,4-dihydronaphthalenes:photofluorogenic lignads for the estrogen receptor" J. Steroid. Biochem. v.23, pp. 929-937, 1985.
"Structure-activity relationship of antiestrogens: a study using . . . " J. Med. Chem. v.32, 1700-1707, 1989.
Crenshaw, R.R., et al, J. Med. Chem. 14 (12) :1185-1190 (1971).
Jones, C.D., et al, J. Med. Chem. 27 : 1057-1066 1984.
Jones, C.D., et al, J. Med. Chem. 35: 931-938 1992.
Cullinan George Joseph
Muehl Brian Stephen
Chang Ceila
Eli Lilly and Company
Voy Gilbert T.
LandOfFree
Naphthyl compounds and compositions, as estrogen receptor bindin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthyl compounds and compositions, as estrogen receptor bindin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyl compounds and compositions, as estrogen receptor bindin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1510099